Drug Shortage Report for APO-CEFADROXIL
Report ID | 190008 |
Drug Identification Number | 02240774 |
Brand name | APO-CEFADROXIL |
Common or Proper name | CEFADROXIL |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | CEFADROXIL |
Strength(s) | 500MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | J01DB |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-04-18 |
Estimated end date | 2024-03-15 |
Actual end date | 2024-03-07 |
Shortage status | Resolved |
Updated date | 2024-03-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v38 | 2024-03-08 | French | Compare |
v37 | 2024-03-08 | English | Compare |
v36 | 2024-03-01 | French | Compare |
v35 | 2024-03-01 | English | Compare |
v34 | 2024-01-26 | French | Compare |
v33 | 2024-01-26 | English | Compare |
v32 | 2023-12-22 | French | Compare |
v31 | 2023-12-22 | English | Compare |
v30 | 2023-10-20 | French | Compare |
v29 | 2023-10-20 | English | Compare |
v28 | 2023-10-06 | French | Compare |
v27 | 2023-10-06 | English | Compare |
v26 | 2023-09-15 | French | Compare |
v25 | 2023-09-15 | English | Compare |
v24 | 2023-09-07 | French | Compare |
v23 | 2023-09-07 | English | Compare |
v22 | 2023-07-27 | French | Compare |
v21 | 2023-07-27 | English | Compare |
v20 | 2023-06-29 | French | Compare |
v19 | 2023-06-29 | English | Compare |